(Q46222428)

English

Successful combination treatment with bevacizumab, thalidomide and autologous PBSC for severe POEMS syndrome

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

20 December 2017

http://europepmc.org/abstract/MED/19043459

Successful combination treatment with bevacizumab, thalidomide and autologous PBSC for severe POEMS syndrome (English)

1 reference

Europe PubMed Central

PubMed publication ID

20 December 2017

http://europepmc.org/abstract/MED/19043459

0 references

1 reference

based on heuristic

inferred from title

Satoshi Kuwabara

14

1 reference

Europe PubMed Central

PubMed publication ID

20 December 2017

http://europepmc.org/abstract/MED/19043459

Masahiro Takeuchi

object named as

M Takeuchi

6

0 references

author name string

C Ohwada

1

1 reference

Europe PubMed Central

PubMed publication ID

20 December 2017

http://europepmc.org/abstract/MED/19043459

C Nakaseko

2

1 reference

Europe PubMed Central

PubMed publication ID

20 December 2017

http://europepmc.org/abstract/MED/19043459

S Sakai

3

1 reference

Europe PubMed Central

PubMed publication ID

20 December 2017

http://europepmc.org/abstract/MED/19043459

Y Takeda

4

1 reference

Europe PubMed Central

PubMed publication ID

20 December 2017

http://europepmc.org/abstract/MED/19043459

D Abe

5

1 reference

Europe PubMed Central

PubMed publication ID

20 December 2017

http://europepmc.org/abstract/MED/19043459

E Sakaida

7

1 reference

Europe PubMed Central

PubMed publication ID

20 December 2017

http://europepmc.org/abstract/MED/19043459

S Masuda

8

1 reference

Europe PubMed Central

PubMed publication ID

20 December 2017

http://europepmc.org/abstract/MED/19043459

N Shimizu

9

1 reference

Europe PubMed Central

PubMed publication ID

20 December 2017

http://europepmc.org/abstract/MED/19043459

R Cho

10

1 reference

Europe PubMed Central

PubMed publication ID

20 December 2017

http://europepmc.org/abstract/MED/19043459

M Nishimura

11

1 reference

Europe PubMed Central

PubMed publication ID

20 December 2017

http://europepmc.org/abstract/MED/19043459

K Kanai

12

1 reference

Europe PubMed Central

PubMed publication ID

20 December 2017

http://europepmc.org/abstract/MED/19043459

S Misawa

13

1 reference

Europe PubMed Central

PubMed publication ID

20 December 2017

http://europepmc.org/abstract/MED/19043459

language of work or name

0 references

publication date

1 December 2008

1 reference

Europe PubMed Central

PubMed publication ID

20 December 2017

http://europepmc.org/abstract/MED/19043459

Bone Marrow Transplantation

1 reference

Europe PubMed Central

PubMed publication ID

20 December 2017

http://europepmc.org/abstract/MED/19043459

43

1 reference

Europe PubMed Central

PubMed publication ID

20 December 2017

http://europepmc.org/abstract/MED/19043459

9

1 reference

Europe PubMed Central

PubMed publication ID

20 December 2017

http://europepmc.org/abstract/MED/19043459

739-740

1 reference

Europe PubMed Central

PubMed publication ID

20 December 2017

http://europepmc.org/abstract/MED/19043459

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2008.381

7 January 2021

based on heuristic

inferred from DOI database lookup

Peripheral blood stem cell transplant for POEMS syndrome is associated with high rates of engraftment syndrome

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2008.381

7 January 2021

based on heuristic

inferred from DOI database lookup

Peripheral blood stem cell transplantation in 16 patients with POEMS syndrome, and a review of the literature

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2008.381

7 January 2021

based on heuristic

inferred from DOI database lookup

Bevacizumab therapy for POEMS syndrome

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2008.381

7 January 2021

based on heuristic

inferred from DOI database lookup

Treatment of POEMS syndrome with bevacizumab

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2008.381

7 January 2021

based on heuristic

inferred from DOI database lookup

Failure of Treatment with Anti-VEGF Monoclonal Antibody for Long-standing POEMS Syndrome

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2008.381

7 January 2021

based on heuristic

inferred from DOI database lookup

Bevacizumab therapy for POEMS syndrome

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2008.381

7 January 2021

based on heuristic

inferred from DOI database lookup

Bevacizumab therapy before autologous stem-cell transplantation for POEMS syndrome

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2008.381

7 January 2021

based on heuristic

inferred from DOI database lookup

Thalidomide reduces serum VEGF levels and improves peripheral neuropathy in POEMS syndrome

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2008.381

7 January 2021

based on heuristic

inferred from DOI database lookup

Superiority of thalidomide and dexamethasone over vincristine-doxorubicindexamethasone (VAD) as primary therapy in preparation for autologous transplantation for multiple myeloma

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2008.381

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1038/BMT.2008.381

1 reference

Europe PubMed Central

PubMed publication ID

20 December 2017

http://europepmc.org/abstract/MED/19043459

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

20 December 2017

http://europepmc.org/abstract/MED/19043459

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q46222428&oldid=2207726888"